Celldex Therapeutics, Inc. Operating Lease, Weighted Average Discount Rate, Percent
Celldex Therapeutics, Inc. (CLDX) had Operating Lease, Weighted Average Discount Rate, Percent of 10.00% as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-02-25
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 10.00%.
- 2024-12-31: Operating Lease, Weighted Average Discount Rate, Percent 10.00%.
- 2023-12-31: Operating Lease, Weighted Average Discount Rate, Percent 10.00%.
- 2022-12-31: Operating Lease, Weighted Average Discount Rate, Percent 10.00%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2025-12-31 | 10.00% 10-K · filed 2026-02-25 |
| 2024-12-31 | 10.00% 10-K · filed 2026-02-25 |
| 2023-12-31 | 10.00% 10-K · filed 2025-02-27 |
| 2022-12-31 | 10.00% 10-K · filed 2024-02-26 |
| 2021-12-31 | 10.00% 10-K · filed 2023-02-28 |
| 2020-12-31 | 10.40% 10-K · filed 2022-02-28 |
| 2019-12-31 | 11.00% 10-K · filed 2021-03-29 |
| 2019-09-30 | 11.20% 10-Q · filed 2019-11-12 |
| 2019-06-30 | 11.30% 10-Q · filed 2019-08-07 |
| 2019-03-31 | 11.30% 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |